Methylprednisolone vs Pembrolizumab
Methylprednisolone vs Pembrolizumab: Overview
This comparison examines the pharmacological differences between Methylprednisolone and Pembrolizumab.
Mechanism of Action
Methylprednisolone: Intermediate-acting synthetic glucocorticoid.
Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.
Pharmacokinetics
Half-life: Methylprednisolone β 18-36 hours; Pembrolizumab β 26 days.
Chemical Properties
Molecular Formula: Methylprednisolone β C22H30O5.
Molecular Weight: Methylprednisolone β 374.4710 g/mol.
Type: Methylprednisolone β Small molecule; Pembrolizumab β Antibody.